1Vidal S, Lloyd RV, Moya L, et al. Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary[J]. J Histochem Cytochem,2002 50(4): 533- 540.
2Toi M, Matsmnoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic imphcations[ J]. Lancet Oncol, 2001,2 ( 11 ) :667 - 673.
3Brekken RA, Thorpe PE. Vascular endothelial growth factor and vascular targeting of solid tumors[J]. Anticancer Res, 2001,21(6B) :4221 - 4229.
4Duyndam MC, Hilhorst MC, Sctduper HM, et al. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts[J].Am J Pathol,2002,160(2) : 537 - 548.
5Olofsson B, Jeltsch M, Eriksson U, et al. Current biology, of VEGF-B and VEGF-C[J]. Curr Opin Biotechnol, 1999, 10(6): 528 -535.
6Wu LW, Mayo LD, Dunbar JD, et al. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation[J]. J Biol Chem,2000,275(7) : 5096 - 5103.
7Lymboussaki A, Achen MG, Stacker SA, et al. Growth factors regulating lymphatic vessels[ J]. Curr Top Microbiol Immunol, 2000,25(1): 75-82.
8Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenie mice expressing soluble VEGF reeeptor-3[J]. Nat Med,2001,7(2): 199-205.
9Kanellis J, Paizis K, Cox AJ, et al. Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression[J]. Kidney Int,2002,61(5) : 1696- 1706.
